Randomized Double Blind Controlled Trial Comparing a Blind Sciatic Nerve Block in the Popliteal Fossa to Intravenous Morphine for Traumatic Severe Acute Pain in the Prehospital Setting
NCT ID: NCT01522534
Last Updated: 2019-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
26 participants
INTERVENTIONAL
2012-01-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of the Early Ultrasound-guided Femoral Nerve Block Performed by Emergency Physicians on Pre-operative Opioids Usage in Patients With Proximal Femoral Fractures
NCT05515718
Sciatic Nerve Block for Ankle and Leg Fracture Manipulation in the Emergency Department
NCT06329752
Duration of Sciatic Nerve Block After Injection of Local Anesthetic In or Around the Nerve
NCT01981291
Continuous Sciatic Nerve Block vs Epidural Analgesia in Lower Limb Amputation for Postoperative Pain
NCT05608733
Pre-post Spinal Popliteal Block
NCT05354791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blind block with mepivacaine
Blind block with mepivacaine and intravenous morphine
Mepivacaine
mepivacaine 1% 20 ml corresponding to 200 mg
Morphine
Intravenous Morphine and placebo blind block
Morphine
Morphine alone with a placebo nerve block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mepivacaine
mepivacaine 1% 20 ml corresponding to 200 mg
Morphine
Morphine alone with a placebo nerve block
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Local infection
* Nerve or vascular pathology in the affected limb, coagulation pathology,
* Chronic use of opoids, use of opoids within 6 hours
* Drug addiction
* Pregnancy
* Systolic blood pressure less than 90 mmHg
* Respiratory rate less than 16 per minute
* Glasgow coma scale \< 14.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Annecy Genevois
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Francois Xavier AGERON, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Annecy Genevois
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier d'Albertville moutiers
Albertville, , France
Centre Hospitalier de la Region d'Annecy
Annecy, , France
Centre Hospitalier de Chambéry
Chambéry, , France
Centre Hospitalier Universitaire de GRENOBLE
Grenoble, , France
Centre medical d'Avoriaz
Morzine, , France
Centre Hospitalier Sallanches Chamonix
Sallanches, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
chra-2009-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.